Objective To provide the first report on the main outcomes from the prevalence and
incidence rounds of a large pilot of routine primary high risk human papillomavirus (hrHPV) …

The development of human papillomavirus (HPV)-based screening should detect more pre-
cancerous changes and so reduce the incidence and mortality from cervical squamous …

Background Sweden revised their cervical cancer screening program in 2017 to include
cytology-based screening for women aged 23–29 years and primary human papillomavirus …

Loss to follow‐up (LTFU) within cervical screening programmes can result in missed
clinically relevant lesions, potentially reducing programme effectiveness. To examine the …

Background: Human papillomavirus (HPV) testing is more sensitive than cytology for
detecting high-grade cervical intraepithelial neoplasia (CIN). We evaluated the performance …

Adding high-risk human papillomavirus (hrHPV) testing to screening increases the efficacy
of cervical screening programmes. However, hrHPV testing may result in a lower …

Background: New screening technologies and vaccination against human papillomavirus
(HPV), the necessary cause of cervical cancer, may impact optimal approaches to prevent …

Background: We evaluated the performance of primary high-risk human papillomavirus
(hrHPV) testing by hybrid capture 2 (HC2) with different thresholds for positivity, in …

Adding a test for high‐risk human papillomavirus (hrHPV) to cytological screening enhances
the detection of high‐grade cervical intraepithelial neoplasia (≥ CIN2), but data are …

Objective To assess the costs and benefits of two algorithms for cervical cancer screening in
Belgium (1) high-risk human papillomavirus (HR-HPV) primary screening and (2) HR-HPV …